<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 19 Feb 2026 07:01:48 +0000</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>NetraMark completes $3.5 million private placement financing</title>
   <link>http://www.streetinsider.com/Equity+Offerings/NetraMark+completes+%243.5+million+private+placement+financing/26025778.html</link>
   <description>

&lt;p&gt;NetraMark Holdings Inc. (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) closed the final tranche of its $3.5 million private placement on February 18, 2026. The Toronto-based artificial intelligence company issued 390,000 units at $1.00 per unit in the second tranche, raising $390,000 in gross proceeds.&lt;/p&gt;

&lt;p&gt;The complete offering consisted of 3.5 million units at $1.00 each. Each unit includes one common share and half of a warrant, with full warrants exercisable at $1.35 per share for two years from the issue date.&lt;/p&gt;

&lt;p&gt;Following the completion, NetraMark has 92,223,699 common shares outstanding. The company plans to use the net proceeds for working capital and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/NetraMark+completes+%243.5+million+private+placement+financing/26025778.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:01:48 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark completes $3.5 million private placement financing</title>
   <link>http://www.streetinsider.com/Equity+Offerings/NetraMark+completes+%243.5+million+private+placement+financing/26025778.html</link>
   <description>

&lt;p&gt;NetraMark Holdings Inc. (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) closed the final tranche of its $3.5 million private placement on February 18, 2026. The Toronto-based artificial intelligence company issued 390,000 units at $1.00 per unit in the second tranche, raising $390,000 in gross proceeds.&lt;/p&gt;

&lt;p&gt;The complete offering consisted of 3.5 million units at $1.00 each. Each unit includes one common share and half of a warrant, with full warrants exercisable at $1.35 per share for two years from the issue date.&lt;/p&gt;

&lt;p&gt;Following the completion, NetraMark has 92,223,699 common shares outstanding. The company plans to use the net proceeds for working capital and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/NetraMark+completes+%243.5+million+private+placement+financing/26025778.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:01:48 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark completes $3.5 million private placement financing</title>
   <link>http://www.streetinsider.com/Equity+Offerings/NetraMark+completes+%243.5+million+private+placement+financing/26025778.html</link>
   <description>

&lt;p&gt;NetraMark Holdings Inc. (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) closed the final tranche of its $3.5 million private placement on February 18, 2026. The Toronto-based artificial intelligence company issued 390,000 units at $1.00 per unit in the second tranche, raising $390,000 in gross proceeds.&lt;/p&gt;

&lt;p&gt;The complete offering consisted of 3.5 million units at $1.00 each. Each unit includes one common share and half of a warrant, with full warrants exercisable at $1.35 per share for two years from the issue date.&lt;/p&gt;

&lt;p&gt;Following the completion, NetraMark has 92,223,699 common shares outstanding. The company plans to use the net proceeds for working capital and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/NetraMark+completes+%243.5+million+private+placement+financing/26025778.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:01:48 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark completes $3.5 million private placement financing</title>
   <link>http://www.streetinsider.com/Equity+Offerings/NetraMark+completes+%243.5+million+private+placement+financing/26025778.html</link>
   <description>

&lt;p&gt;NetraMark Holdings Inc. (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) closed the final tranche of its $3.5 million private placement on February 18, 2026. The Toronto-based artificial intelligence company issued 390,000 units at $1.00 per unit in the second tranche, raising $390,000 in gross proceeds.&lt;/p&gt;

&lt;p&gt;The complete offering consisted of 3.5 million units at $1.00 each. Each unit includes one common share and half of a warrant, with full warrants exercisable at $1.35 per share for two years from the issue date.&lt;/p&gt;

&lt;p&gt;Following the completion, NetraMark has 92,223,699 common shares outstanding. The company plans to use the net proceeds for working capital and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/NetraMark+completes+%243.5+million+private+placement+financing/26025778.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:01:48 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Closes Final Tranche of $3.5 Million Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  19, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, is pleased to announce that the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news releases dated January 13, 2026 and January 28, 2026) closed on February 18, 2026. Under the Second Tranche, the Company issued 390,000 units of the Company (the “Units”) at a price of $1.00 per Unit for</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Closes Final Tranche of $3.5 Million Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  19, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, is pleased to announce that the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news releases dated January 13, 2026 and January 28, 2026) closed on February 18, 2026. Under the Second Tranche, the Company issued 390,000 units of the Company (the “Units”) at a price of $1.00 per Unit for</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Closes Final Tranche of $3.5 Million Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  19, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, is pleased to announce that the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news releases dated January 13, 2026 and January 28, 2026) closed on February 18, 2026. Under the Second Tranche, the Company issued 390,000 units of the Company (the “Units”) at a price of $1.00 per Unit for</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Closes Final Tranche of $3.5 Million Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  19, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, is pleased to announce that the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news releases dated January 13, 2026 and January 28, 2026) closed on February 18, 2026. Under the Second Tranche, the Company issued 390,000 units of the Company (the “Units”) at a price of $1.00 per Unit for</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Closes Final Tranche of $3.5 Million Private Placement</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  19, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, is pleased to announce that the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news releases dated January 13, 2026 and January 28, 2026) closed on February 18, 2026. Under the Second Tranche, the Company issued 390,000 units of the Company (the “Units”) at a price of $1.00 per Unit for</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Closes Final Tranche of $3.5 Million Private Placement</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  19, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, is pleased to announce that the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news releases dated January 13, 2026 and January 28, 2026) closed on February 18, 2026. Under the Second Tranche, the Company issued 390,000 units of the Company (the “Units”) at a price of $1.00 per Unit for</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Closes Final Tranche of $3.5 Million Private Placement</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  19, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, is pleased to announce that the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news releases dated January 13, 2026 and January 28, 2026) closed on February 18, 2026. Under the Second Tranche, the Company issued 390,000 units of the Company (the “Units”) at a price of $1.00 per Unit for</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Closes Final Tranche of $3.5 Million Private Placement</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  19, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, is pleased to announce that the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news releases dated January 13, 2026 and January 28, 2026) closed on February 18, 2026. Under the Second Tranche, the Company issued 390,000 units of the Company (the “Units”) at a price of $1.00 per Unit for</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NetraMark+Closes+Final+Tranche+of+%243.5+Million+Private+Placement/26025772.html</guid>
   <pubDate>Thu, 19 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>Netramark Announces Uplisting to Toronto Stock Exchange</title>
   <link>http://www.streetinsider.com/Press+Releases/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  13, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a company focused on AI-driven clinical trial optimization and precision patient stratification, today announced that it will be uplisting to the Toronto Stock Exchange (the “TSX“). The common shares of the Company (the “Common Shares“) will be voluntarily delisted from the Canadian Securities Exchange (the “CSE“) effective as of close of market on February 17, 2026, and will commence trading on the TSX effective at market open on February 18, 2026 under its current stock symbol “AIAI”.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</guid>
   <pubDate>Fri, 13 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>Netramark Announces Uplisting to Toronto Stock Exchange</title>
   <link>http://www.streetinsider.com/Press+Releases/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  13, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a company focused on AI-driven clinical trial optimization and precision patient stratification, today announced that it will be uplisting to the Toronto Stock Exchange (the “TSX“). The common shares of the Company (the “Common Shares“) will be voluntarily delisted from the Canadian Securities Exchange (the “CSE“) effective as of close of market on February 17, 2026, and will commence trading on the TSX effective at market open on February 18, 2026 under its current stock symbol “AIAI”.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</guid>
   <pubDate>Fri, 13 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>Netramark Announces Uplisting to Toronto Stock Exchange</title>
   <link>http://www.streetinsider.com/Press+Releases/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  13, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a company focused on AI-driven clinical trial optimization and precision patient stratification, today announced that it will be uplisting to the Toronto Stock Exchange (the “TSX“). The common shares of the Company (the “Common Shares“) will be voluntarily delisted from the Canadian Securities Exchange (the “CSE“) effective as of close of market on February 17, 2026, and will commence trading on the TSX effective at market open on February 18, 2026 under its current stock symbol “AIAI”.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</guid>
   <pubDate>Fri, 13 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>Netramark Announces Uplisting to Toronto Stock Exchange</title>
   <link>http://www.streetinsider.com/Press+Releases/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  13, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a company focused on AI-driven clinical trial optimization and precision patient stratification, today announced that it will be uplisting to the Toronto Stock Exchange (the “TSX“). The common shares of the Company (the “Common Shares“) will be voluntarily delisted from the Canadian Securities Exchange (the “CSE“) effective as of close of market on February 17, 2026, and will commence trading on the TSX effective at market open on February 18, 2026 under its current stock symbol “AIAI”.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</guid>
   <pubDate>Fri, 13 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>Netramark Announces Uplisting to Toronto Stock Exchange</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  13, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a company focused on AI-driven clinical trial optimization and precision patient stratification, today announced that it will be uplisting to the Toronto Stock Exchange (the “TSX“). The common shares of the Company (the “Common Shares“) will be voluntarily delisted from the Canadian Securities Exchange (the “CSE“) effective as of close of market on February 17, 2026, and will commence trading on the TSX effective at market open on February 18, 2026 under its current stock symbol “AIAI”.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</guid>
   <pubDate>Fri, 13 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>Netramark Announces Uplisting to Toronto Stock Exchange</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  13, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a company focused on AI-driven clinical trial optimization and precision patient stratification, today announced that it will be uplisting to the Toronto Stock Exchange (the “TSX“). The common shares of the Company (the “Common Shares“) will be voluntarily delisted from the Canadian Securities Exchange (the “CSE“) effective as of close of market on February 17, 2026, and will commence trading on the TSX effective at market open on February 18, 2026 under its current stock symbol “AIAI”.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</guid>
   <pubDate>Fri, 13 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>Netramark Announces Uplisting to Toronto Stock Exchange</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  13, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a company focused on AI-driven clinical trial optimization and precision patient stratification, today announced that it will be uplisting to the Toronto Stock Exchange (the “TSX“). The common shares of the Company (the “Common Shares“) will be voluntarily delisted from the Canadian Securities Exchange (the “CSE“) effective as of close of market on February 17, 2026, and will commence trading on the TSX effective at market open on February 18, 2026 under its current stock symbol “AIAI”.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</guid>
   <pubDate>Fri, 13 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>Netramark Announces Uplisting to Toronto Stock Exchange</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  13, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a company focused on AI-driven clinical trial optimization and precision patient stratification, today announced that it will be uplisting to the Toronto Stock Exchange (the “TSX“). The common shares of the Company (the “Common Shares“) will be voluntarily delisted from the Canadian Securities Exchange (the “CSE“) effective as of close of market on February 17, 2026, and will commence trading on the TSX effective at market open on February 18, 2026 under its current stock symbol “AIAI”.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Netramark+Announces+Uplisting+to+Toronto+Stock+Exchange/25995391.html</guid>
   <pubDate>Fri, 13 Feb 2026 07:00:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Strengthens Board Of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;TORONTO, Jan.  29, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).&lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.&lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html</guid>
   <pubDate>Thu, 29 Jan 2026 08:30:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02865479</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.23610225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38374316</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214698</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EMO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HPM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBLC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00392811</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05079513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09232287</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19741769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34925378</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46878772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54441446</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Strengthens Board Of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;TORONTO, Jan.  29, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).&lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.&lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html</guid>
   <pubDate>Thu, 29 Jan 2026 08:30:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02865479</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.23610225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38374316</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214698</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EMO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HPM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBLC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00392811</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05079513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09232287</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19741769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34925378</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46878772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54441446</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Strengthens Board Of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;TORONTO, Jan.  29, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).&lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.&lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html</guid>
   <pubDate>Thu, 29 Jan 2026 08:30:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02865479</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.23610225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38374316</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214698</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EMO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HPM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBLC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00392811</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05079513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09232287</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19741769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34925378</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46878772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54441446</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Strengthens Board Of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;TORONTO, Jan.  29, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).&lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.&lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html</guid>
   <pubDate>Thu, 29 Jan 2026 08:30:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02865479</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.23610225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38374316</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214698</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EMO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HPM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBLC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00392811</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05079513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09232287</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19741769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34925378</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46878772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54441446</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
  <item>
   <title>NetraMark Strengthens Board Of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;TORONTO, Jan.  29, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)&lt;/strong&gt;, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).&lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.&lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0pt;&quot;&gt;Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html</guid>
   <pubDate>Thu, 29 Jan 2026 08:30:00 +0000</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02865479</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.23610225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38374316</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214698</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AIAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AINMF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EMO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HPM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBLC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00392811</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05079513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09232287</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19741769</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34925378</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46878772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52416069</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54441446</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PF0</category>
   	  </item>
 </channel>
</rss>
